What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?

To determine whether the post-external beam radiotherapy (RT) prostate-specific antigen nadir (nPSA) improves our ability to predict freedom from PSA failure, progression-free survival (PFS), and overall survival. Controversy regarding the importance of nPSA after external beam RT as a prognostic in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Urology (Ridgewood, N.J.) N.J.), 2003-09, Vol.62 (3), p.492-496
Hauptverfasser:	DeWitt, K.D, Sandler, H.M, Weinberg, V, McLaughlin, P.W, Roach, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - diagnosis Adenocarcinoma - mortality Adenocarcinoma - radiotherapy Age Factors Aged Aged, 80 and over Biological and medical sciences Biomarkers, Tumor - analysis Disease-Free Survival Follow-Up Studies Humans Male Medical sciences Middle Aged Multivariate Analysis Neoplasm Staging Nephrology. Urinary tract diseases Prostate-Specific Antigen - analysis Prostatic Neoplasms - diagnosis Prostatic Neoplasms - mortality Prostatic Neoplasms - radiotherapy Risk Assessment Survival Rate Treatment Failure Tumors of the urinary system Urinary tract. Prostate gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!